Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Stryker, SeaSpine and Innovasis Ink New Licensing Deals

Companies continue to fill gaps and enhance their product offerings by choosing strategic partners that can get them where they want to be. In just the last two weeks, Stryker, SeaSpine and Innovasis entered agreements that provide each company with new technologies for their portfolio.

Stryker to License Conformis’ PSI Technology

Conformis agreed to sell and license aspects of its patient-specific instrumentation (PSI) technology to Stryker. (The company's iTotal PS is pictured above.) PSI creates single-use, patient-specific instruments from a CT-based 3D model. Conformis will receive $14 million upfront and an additional $16 million in milestone payments for selling, licensing and developing part of its intellectual property. The payments are split between $5 million upon the first prototype and completion of the design, and $11 million upon first FDA 510(k) clearance. The companies also entered into a long-term distribution agreement to manufacture PSI for Stryker, including for the Triathlon Total Knee System.

The deal gives Stryker further differentiation in their knee portfolio as they prepare to fend off renewed competitive pressure from Zimmer Biomet amid the ROSA Knee ramp up. Taken together with Stryker’s acquisition of sterilization specialist TSO3, the deal with Conformis shows that the company seeks to drive efficiencies in instrumentation, a common economic and logistical challenge for customers.

SeaSpine Accesses 3D-Printing with restor3d Deal

SeaSpine gains entry into the 3D-printed interbody arena through an exclusive development and licensing agreement with restor3d, developer of 3D-printed implants. restor3d was co-founded by Ken Gall, Professor of Mechanical Engineering at Duke University and veteran in the study of materials processing, structure and mechanical properties. Dr. Gall also sits on the board of restor3D.

restor3d’s materials science technology complements SeaSpine’s orthobiologic portfolio. Together, the two companies will leverage their specialties to develop interbodies for a wide range of surgical approaches, while driving both clinical and economic advantages.

“restor3d's well-researched architecture provides a foundation for novel 3D interbody designs that thoughtfully balance structural integrity with the biological requirements for bony integration and fusion,” said Shaeffer Bannigan, Senior Director of Product Development at SeaSpine. “This allows us to tune implant properties to optimal performance, merging biomechanical requirements with biologically favorable materials and structures.”

SeaSpine expects to launch products arising from this collaboration in 2H20.

Innovasis Signs New HA Peek Deal

Innovasis signed an exclusive deal to use Pore Matrix’s Porous Hydroxyapatite (HA) PEEK in interbody devices. The material has a modulus close to bone and incorporates a scaffold for bone ingrowth. Its patented architecture is spherical and interconnected throughout the device, for density that is similar to cancellous bone. HA will be incorporated throughout the implant.

Innovasis employs HA PEEK in its interbody devices for cervical and thoracolumbar fusion.

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant.